Cargando…
Monoclonal antibody as a potential anti-COVID-19
Coronavirus disease 2019 (COVID-19) is expanding rapidly, which made it as one of top priorities for scientists to develop novel treatment strategies. Researchers are racing to develop treatments based on antibodies to block and/or neutralize the coronavirus in affected patients. Initially, the gene...
Autores principales: | Jahanshahlu, Leila, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269943/ https://www.ncbi.nlm.nih.gov/pubmed/32534226 http://dx.doi.org/10.1016/j.biopha.2020.110337 |
Ejemplares similares
-
Central Nervous System Involvement in COVID-19
por: Jahanshahlu, Leila, et al.
Publicado: (2020) -
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
por: Saghazadeh, Amene, et al.
Publicado: (2020) -
Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
por: Douedi, Steven, et al.
Publicado: (2020) -
Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022) -
Establishment of anti-mesothelioma monoclonal antibodies
por: Mizutani, Natsuko, et al.
Publicado: (2016)